Dr Toinét Cronjé

Toinét is Scientific Vice President at Sequoia Genetics, where she provides scientific leadership across client projects and leads its Translational Team. She oversees scientific delivery, mentors and develops researchers, and ensures the highest standards of scientific rigour and quality. With expertise in multi-omics analysis and drug-target Mendelian randomisation, she guides projects from study design and data integration through to interpretation, translating complex scientific evidence into actionable insights that inform drug discovery and development decisions.

Toinét holds a PhD in Health Science from North-West University, South Africa, where she investigated the role of DNA methylation in the relationship between urbanisation and cardiometabolic disease. She also earned a BSc in Health Science (Psychology and Nutrition) and an MSc in Health Science (Nutrition) from the same institution. She subsequently completed three years of postdoctoral research in Europe, focusing on proteomic biomarkers of disease, before specialising in drug-target Mendelian randomisation through roles spanning academia and industry.